Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date Reda M. ChalhoubPeter W. Kalivas Leading Article 10 August 2020 Pages: 1509 - 1524
Movement of Poly-ADP Ribose (PARP) Inhibition into Frontline Treatment of Ovarian Cancer Michaela OnstadRobert L. ColemanShannon N. Westin Leading Article 27 August 2020 Pages: 1525 - 1535
Assessment of Cardiovascular Safety of Anti-Osteoporosis Drugs N. R. FuggleC. CooperJ. Y. Reginster Review Article Open access 28 July 2020 Pages: 1537 - 1552
Management of Thrombotic Complications in COVID-19: An Update Adrija HajraSheetal Vasundara MathaiWilbert S. Aronow Review Article 16 August 2020 Pages: 1553 - 1562
Deprescribing Opioids in Chronic Non-cancer Pain: Systematic Review of Randomised Trials Stephanie MathiesonChristopher G. MaherChung-Wei Christine Lin Systematic Review 31 July 2020 Pages: 1563 - 1576
Correction to: Deprescribing Opioids in Chronic Non‑cancer Pain: Systematic Review of Randomised Trials Stephanie MathiesonChristopher G. MaherChung-Wei Christine Lin Correction 29 September 2020 Pages: 1577 - 1578
Apalutamide: A Review in Metastatic Castration-Sensitive Prostate Cancer Sheridan M. Hoy Adis Drug Evaluation 15 September 2020 Pages: 1579 - 1585
Atezolizumab: A Review in Extensive-Stage SCLC James E. Frampton Adis Drug Evaluation 29 September 2020 Pages: 1587 - 1594
Triheptanoin: First Approval Matt Shirley AdisInsight Report Open access 08 September 2020 Pages: 1595 - 1600
Bulevirtide: First Approval Connie KangYahiya Y. Syed AdisInsight Report 14 September 2020 Pages: 1601 - 1605
Belantamab Mafodotin: First Approval Anthony Markham AdisInsight Report 16 September 2020 Pages: 1607 - 1613
Correction to: Fostemsavir: First Approval Anthony Markham Correction 09 September 2020 Pages: 1615 - 1615
